comment

Why fashion is going backwards when it comes to women’s bodies

Thanks to Ozempic, thin is back in, and British Vogue’s Chioma Nnadi says we should all be concerned. Olivia Petter explains why body positivity is a trend that appears to be over

Saturday 16 November 2024 14:42 GMT
Comments
Rumours of Ozempic use are rife in Hollywood

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Finally, someone has said it: thin is in again, and it’s not good. Actually, it’s very worrying, as was astutely put this week by none other than Chioma Nnadi, head of editorial content at British Vogue.

Speaking on the BBC’s Today programme, the magazine editor blamed the proliferation of extreme skinniness on runways on the rise of Ozempic. “We should all be concerned,” she said. “I am very concerned, and I know many of my colleagues are very concerned, and I do think perhaps Ozempic has something to do with it.”

Nnadi added: “We’re part of this moment where we’re seeing the pendulum swing back to skinny being in, and often these things are treated like a trend, and we don’t want them to be.”

Ozempic is a brand name for a drug called semaglutide, which is used to treat type 2 diabetes but has been prescribed off-label for weight loss. The drug works by mimicking the effects of a hormone called GLP-1, which is released after eating and makes you feel full. In the UK, semaglutide is sold under the brand name Wegovy.

For a while now, rumours have percolated the internet about which celebrities are thought to have taken it in an effort to shed pounds. And, as the drug has become more widely accessible to those who don’t need it (I was able to fudge my answers on an online pharmacy’s website to acquire a prescription a few months ago), all sorts of alarm bells have been ringing about what this is doing to our bodies and minds.

Until now, those alarm bells have rung somewhat dimly in fashion circles, which is ironic considering that the fashion industry has been one of the main focuses of this growing problem.

Sure, there have been murmurings, like when the fashion director at The New York Times, Vanessa Friedman, tweeted in February 2023: “Even I am distracted by the extreme skinniness of many of the models in Jason Wu’s show.” She later clarified: “I have been around a lot of eating disorders in my life, as well as lots of naturally thin people, and the difference between the two is not hard to recognise. I can tell you at least two of the models fell into this category.”

Beyond that, though, this is a problem most fashion people seem to have either long dismissed or ignored.

I’ve been going to fashion shows for seven years, and I can safely say that no amount of body positivity has changed the brazen fact that the majority of models on those catwalks are very thin. The message is, and always has been, simple: beauty is synonymous with slimness, and always will be.

I’m afraid that’s still the case when some designers decide to cast one or two “plus-size” models, which only ever seems like tokenism. And while there are plenty of smaller brands casting more diverse body types in their shows – think Sinead O’Dwyer, Karoline Vitto, and Di Petsa – nothing is really going to move the needle until the major labels take action.

According to data compiled by model and body positivity campaigner Felicity Hayward, and published by Glamour, the number of plus-size models during London Fashion Week has been steadily increasing since 2022, with 80 out of 2,000 models considered “curve” or “plus”. But elsewhere, designers are lagging behind: just 14 out of 2,888 models were plus-size in Milan, and just 43 out of 4,500 in Paris.

These figures tell a dismal story, which is that fashion still has an incredibly limited view of beauty – one that is causing widespread harm to women everywhere. The thing is, even if you’re outside the fashion world, it’s those catwalks that set the precedent for everything else, from the campaigns we see in high-street shops to the photographs that appear in magazines and on social media.

It’s brilliant that Nnadi has raised this issue, least of all because she’s at the helm of one of the industry’s most defining titles, and designers are likely to listen to her. But it’s going to take a lot more than one person to invoke meaningful change here. For far too long, the fashion industry has celebrated thin bodies. Now, with Ozempic, that celebration feels more dangerous than ever.

It’s particularly sad when you consider how, a few years ago, there was so much talk about body positivity, and even body neutrality. But given the current state of things, as Nnadi put it, it’s hard not to look at those shifts as simply trends. And what worries me most is that those trends appear to be over.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in